Some robust pipelines: Glaxo Oncology, and J&J. Cephalon moving more rapidly on oncology candidate Treanda. Glaxo's cervical cancer vaccine Cervarix looking good. Byetta, a diabetes drug from …
Pharma News 6_8
An Oncology News-fest, during ASCO week: Genentech's Avastin shown to be helpful for kidney cancer. Bayer/Onyx's Nexavar shows hopeful activity for liver cancer. Pfizer's still-experimental …
Global Avandia Lawsuit – “We’re in it to Win it!” says Firm
The Boston-based law firm of Rosiglitazone, Metformin & Sitaliptin has taken the unprecedented step of filing a global tort lawsuit on behalf of 6 billion residents of Planet Earth, charging a …
Continue Reading about Global Avandia Lawsuit – “We’re in it to Win it!” says Firm →
Pharma Web Branding, Part 2 – GlaxoSmithKline
In my continuing series on how pharmaceutical companies engage the public with their brand on their website homepages, this week we'll take a look at GlaxoSmithKline's home page, www.gsk.com (last …
Continue Reading about Pharma Web Branding, Part 2 – GlaxoSmithKline →
GlaxoSmithKline, Avandia, and Lawyers
I'd be willing to bet that the first lawsuits will be filed as early as today or tomorrow. Back story: one meta-analysis indicates that treatment with GSK's diabetes drug Avandia is associated with a …
Continue Reading about GlaxoSmithKline, Avandia, and Lawyers →